The physiological factors that may mitigate COVID-19 in CF patients could be the localized respiratory tract reduction of IL-6, thick secretions in the respiratory tract, existing microbiota, and elevated autophagy induction [58]. The gene discussed is IL6; the disease is cystic fibrosis.